CD8A and neoplasm: De Jong et al. investigated the number of tumor-infiltrating CD8+ and FoxP3+ T-lymphocytes in 368 endometrial cancers by immunohistochemistry, and indicated that a high CD8+/FOXP3+ ratio was significantly associated with a better disease-free survival [50].